Better Therapeutics, Inc. (BTTX)

NASDAQ: BTTX · IEX Real-Time Price · USD
1.43
-0.03 (-1.99%)
At close: Dec 1, 2022 2:45 PM
1.42
-0.01 (-0.77%)
After-hours: Dec 1, 2022 7:08 PM EST
-1.99%
Market Cap 34.67M
Revenue (ttm) n/a
Net Income (ttm) -43.70M
Shares Out 23.69M
EPS (ttm) -2.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,195
Open 1.53
Previous Close 1.46
Day's Range 1.41 - 1.53
52-Week Range 0.91 - 7.19
Beta 0.03
Analysts Buy
Price Target 17.34 (+1,111.7%)
Earnings Date Nov 14, 2022

About BTTX

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a... [Read more]

Industry Biotechnology
Founded 2015
Employees 44
Stock Exchange NASDAQ
Ticker Symbol BTTX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for BTTX stock is "Buy." The 12-month stock price forecast is 17.34, which is an increase of 1,111.74% from the latest price.

Price Target
$17.34
(1,111.74% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Better Therapeutics to Participate in BTIG Digital Health Forum

SAN FRANCISCO--( BUSINESS WIRE )--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes...

2 weeks ago - Business Wire

Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

SAN FRANCISCO--( BUSINESS WIRE )--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the...

2 weeks ago - Business Wire

Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the r...

3 weeks ago - Business Wire

Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the r...

1 month ago - Business Wire

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market

In October 2021, I made a big call on Longeveron (NASDAQ: LGVN ) stock, a biotech firm working on a promising Alzheimer's therapy.

1 month ago - InvestorPlace

Positive Results from Pivotal Trial of Better Therapeutics' Investigational BT-001 Prescription Digital Therapy for T...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the r...

1 month ago - Business Wire

Better Therapeutics Submits De Novo Request to U.S. FDA for BT-001 Investigational Prescription Digital Therapy for T...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the r...

2 months ago - Business Wire

Better Therapeutics to Participate in Three Upcoming Investor Conferences

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

2 months ago - Business Wire

Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

3 months ago - Business Wire

Better Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

3 months ago - Business Wire

Why Is Better Therapeutics (BTTX) Stock Up 27% Today?

Source: Minerva Studio / Shutterstock.com Better Therapeutics (NASDAQ: BTTX ) stock is rocketing higher on Thursday as investors react to results from a Phase 2 clinical trial. This Phase 2 study saw Be...

4 months ago - InvestorPlace

Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint R...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a prescription digital therapeutics company developing nutritional cognitive behavioral therapy (nCBT) to...

4 months ago - Business Wire

Better Therapeutics to Host Conference Call to Review Results from Pivotal Clinical Trial of BT-001 for Type 2 Diabetes

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

4 months ago - Business Wire

Better Therapeutics Announces Publication of the Rationale, Design and Baseline Characteristics Manuscript for Type 2...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics company developing nutritional cognitive behavioral therapy (nCBT) to address the root cause...

4 months ago - Business Wire

3 Penny Stocks That Have Huge Catalysts Ahead

While you don't want to play with money you can't afford to lose, these penny stocks might bring home the goods for the bold. The post 3 Penny Stocks That Have Huge Catalysts Ahead appeared first on Inv...

Other symbols: GEVOOPTT
5 months ago - InvestorPlace

Better Therapeutics to Participate in Cowen 7th Annual FutureHealth Conference

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

5 months ago - Business Wire

Better Therapeutics to Participate in Cowen's Unlocking the Value of Digital Prescription Therapeutics Webinar on Jun...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

5 months ago - Business Wire

Better Therapeutics Announces Issuance of U.S. Patent Covering Key Features of Their Prescription Digital Therapeutic...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

5 months ago - Business Wire

Better Therapeutics Appoints Frank Karbe as Chief Executive Officer

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

5 months ago - Business Wire

Short Squeeze Stocks: RDBX, BTTX and 3 Others Experts Think Are Ready to Pop

This week's list of potential short squeeze stocks from Fintel is certainly drawing attention, with some big names featured on the list. The post Short Squeeze Stocks: RDBX, BTTX and 3 Others Experts Th...

Other symbols: EOSE
6 months ago - InvestorPlace

5 Short Squeeze Candidates To Watch This Week: Redbox Tops List With Huge Numbers, GameStop Rejoins The Leaderboard A...

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Other symbols: GMEEOSEFUV
6 months ago - Benzinga

Better Therapeutics Reports First Quarter 2022 Financial Results and Provides Update on Key Corporate Milestones

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

6 months ago - Business Wire

Better Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 13, 2022

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

6 months ago - Business Wire

Why Is Better Therapeutics (BTTX) Stock Up 30% Today?

Better Therapeutics (BTTX) stock is rising higher on heavy trading Monday despite a lack of news from the biotechnology company. The post Why Is Better Therapeutics (BTTX) Stock Up 30% Today?

6 months ago - InvestorPlace

Better Therapeutics Announces Key Milestones and Updates for Ongoing Studies of its Digital Therapeutics Approach for...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root...

7 months ago - Business Wire